Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tracy Dale Wilkins is active.

Publication


Featured researches published by Tracy Dale Wilkins.


Toxicology Letters | 1986

Stimulation of enzyme secretion from isolated pan- creatic acini by clostridium difficile toxin B

Gwendolyn D. Vesenka; Adhip P.N. Majumdar; Michael A. Dubick; David M. Lyerly; Tracy Dale Wilkins; Joseph Silva; Michael C. Geokas

Exposure of isolated rat pancreatic acini to increasing concentrations (10 ng - 800 ng/ml) of toxin B from Clostridium difficile produced a biphasic effect on the rate of secretion of amylase, trypsinogen, and chymotrypsinogen. Whereas doses of toxin B from 10-30 ng/ml increased enzyme secretion by 15-20%, doses between 30 ng and 60 ng/ml showed a regression of this effect, whereafter the rate of secretion of amylase, trypsinogen, and chymotrypsinogen increased with increasing concentrations of the toxin. Toxin B concentration of 800 ng/ml enhanced amylase, trypsinogen and chymotrypsinogen secretion by 119%, 185% and 195%, respectively, when compared with the basal level. Stimulation of enzyme secretion by toxin B was not affected by the presence of either actinomycin-D or cycloheximide, at a concentration which inhibited acinar RNA or protein synthesis by 80-90%. Although toxin B as well as CCK8, carbachol and secretin by themselves caused significant stimulation in amylase, trypsinogen and chymotrypsinogen secretion from isolated pancreatic acini, toxin B together with either CCK8, carbachol or secretin produced no further augmentation in enzyme secretion than what was observed with the secretagogues alone. It is concluded that toxin B of Cl. difficile exerts a direct effect on pancreatic acinar cells as evidenced by stimulation of enzyme secretion.


Archive | 2000

Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines

Tracy Dale Wilkins; David M. Lylerly; J. Scott Moncrief; Danka Pavliakova; Rachel Scheerson; John B. Robbins


Archive | 2006

The Enterotoxic Clostridia

Bruce A. McClane; Francisco A. Uzal; Mariano E. Fernandez Miyakawa; David Lyerly; Tracy Dale Wilkins


Archive | 1985

Vaccines based on insoluble supports

Tracy Dale Wilkins; David Maxwell Lyerly


Archive | 1982

Toxins and antibodies of C. difficile

Tracy Dale Wilkins; David Maxwell Lyerly


Archive | 2001

Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker

James H. Boone; David Maxwell Lyerly; Tracy Dale Wilkins; Richard L. Guerrant


Archive | 2003

Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel

James H. Boone; David Maxwell Lyerly; Tracy Dale Wilkins


Archive | 2000

Recombinant toxin A/toxin B vaccine against Clostridium difficile

Tracy Dale Wilkins; David Maxwell Lyerly; J. Scott Moncrief; Limin Zheng; Carol Phelps


Archive | 2005

Device and Method for Detection of Analytes

James H. Boone; David Maxwell Lyerly; Tracy Dale Wilkins


Archive | 2002

Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae

James H. Boone; David Maxwell Lyerly; Tracy Dale Wilkins

Collaboration


Dive into the Tracy Dale Wilkins's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

James H. Boone

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Danka Pavliakova

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John B. Robbins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge